Concepedia

Author

David Geffen

Ben-Gurion University of the NegevORCID

Also Known As

D B Geffen, D. B. Geffen, D. Geffen, D.B. Geffen, DAVID B. GEFFEN, David B Geffen, David B. Geffen, David Barry Geffen, David Geffen, David B. Geffen

130

Publications

2K

Citations

21

H-Index

68

Concepts

All Affiliations

Ben-Gurion University of the NegevSoroka Medical CenterTel Aviv UniversityRabin Medical CenterKaplan Medical Center
DG

About

David Geffen is an author at Ben-Gurion University of the Negev specializing in medicine, pathology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

17

990

2

Health Sciences

3

3

603

3

Education

1

1

11

4

Nursing

1

1

13

5

Allergy

1

1

12

David Geffen

×

36

Publications

1.7K

Citations

19

H-Index

YearCitations

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen,

The Lancet Oncology

2017

578

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Thomas Bachelot, Eva Ciruelos, Fabio Puglisi,

Annals of Oncology

2019

111

Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry

Salomon M. Stemmer, Mariana Steiner, Shulamith Rizel,

npj Breast Cancer

2017

85

Metastatic tumors to the jaws: a report of eight new cases.

L. Bodner, Netta Sion‐Vardy, David Geffen,

PubMed

2006

79

Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry

Salomon M. Stemmer, Mariana Steiner, Shulamith Rizel,

npj Breast Cancer

2017

68

The impact of the 21-gene recurrence score assay on decision making about adjuvant chemotherapy in early-stage estrogen-receptor-positive breast cancer in an oncology practice with a unified treatment policy

David Geffen, Sara Abu‐Ghanem, N. Sion‐Vardy,

Annals of Oncology

2011

66

Association between standard clinical and pathologic characteristics and the 21‐gene recurrence score in breast cancer patients

Ido Wolf, Noa Ben‐Baruch, Ronnie Shapira‐Frommer,

Cancer

2007

58

Post-traumatic Stress Disorder and Quality of Life in Long-term Survivors of Hodgkin's Disease and Non-Hodgkin's Lymphoma in Israel

David Geffen, Anat Blaustein, Marianne Amir,

Leukemia & lymphoma/Leukemia and lymphoma

2003

57

Alveolar bone necrosis and tooth loss: A rare complication associated with herpes zoster infection of the fifth cranial nerve

William E. Wright, M. L. Davis, David Geffen,

Oral Surgery Oral Medicine Oral Pathology

1983

57

Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer

Ella Evron, A. Ben-David, H. Goldberg,

Annals of Oncology

2018

54

Page 1